Home  >  Products  >  D2HGDH (D-2-hydroxyglutarate dehydrogenase ) Blocking Peptide (the C terminal of D2HGDH)(100ug)
D2HGDH (D-2-hydroxyglutarate dehydrogenase ) Blocking Peptide (the C terminal of D2HGDH)(100ug)

D2HGDH (D-2-hydroxyglutarate dehydrogenase ) Blocking Peptide (the C terminal of D2HGDH)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-D2HGDH Antibody (ARP66551_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66551
Size: 100ug
Weight: 55kDa
Gene: 728294
Format: Lyophilized powder
Target: This gene encodes D-2hydroxyglutarate dehydrogenase, a mitochondrial enzyme belonging to the FAD-binding oxidoreductase/transferase type 4 family. This enzyme, which is most active in liver and kidney but also active in heart and brain, converts D-2-hydroxyglutarate to 2-ketoglutarate. Mutations in this gene are present in D-2-hydroxyglutaric aciduria, a rare recessive neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features.
Alternative names: D2HGD; FLJ42195; MGC25181
See Full Product Listings >